Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Abandoned fishing gear: a new monitoring protocol for assessing the impact on shallow and deep coralligenous reefs.

Marine environmental research·2026

Same author

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same author

Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

ESMO open·2025

Same author

Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients.

Prostate cancer and prostatic diseases·2025

Same author

Mycoplasma bovis pneumonia in marsh deer (Blastocerus dichotomus) from a natural reserve of Argentina.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Imaging of NETs with PET radiopharmaceuticals.

V Ambrosini¹, P Tomassetti, R Franchi

¹Department of Nuclear Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of

|February 20, 2010

Summary

Positron emission tomography (PET) offers superior neuroendocrine tumour (NET) imaging accuracy compared to older methods. Novel radiotracers like [18F]DOPA and [68Ga]DOTA-peptides show great promise for diagnosing NET.

More Related Videos

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of ⁶⁸Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of ⁶⁸Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Area of Science:

Nuclear Medicine
Oncology
Radiochemistry

Background:

Neuroendocrine tumours (NET) diagnosis has historically presented significant challenges.
Somatostatin receptor scintigraphy improved diagnostic accuracy, but newer techniques offer further advancements.

Purpose of the Study:

To review the advancements in positron emission tomography (PET) imaging for neuroendocrine tumours (NET).
To highlight the role of novel radiotracers in enhancing NET detection and characterization.

Main Methods:

Review of current literature on PET imaging in NET diagnosis.
Comparison of various PET radiotracers, including metabolic and receptor-based agents.
Discussion of emerging imaging agents targeting specific NET receptors.

Main Results:

PET imaging provides higher spatial resolution and accuracy for NET detection compared to traditional methods.
[18F]DOPA and [68Ga]DOTA-peptides ([68Ga]Ga-DOTA-TOC, [68Ga]Ga-DOTA-NOC, [68Ga]Ga-DOTA-TATE) demonstrate high efficacy in visualizing well-differentiated NET.
[18F]FDG PET is valuable for less differentiated NET but limited in well-differentiated types due to low metabolic activity.

Conclusions:

PET imaging, particularly with novel radiotracers, represents a significant advancement in the accurate diagnosis and characterization of neuroendocrine tumours.
Ongoing research into new imaging agents promises further improvements in personalized NET management.